ISSN: 2167-065X

臨床薬理学および生物薬剤学

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • CAS ソース インデックス (CASSI)
  • 索引コペルニクス
  • Google スカラー
  • シェルパ・ロミオ
  • Genamics JournalSeek
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

Assessment of the Prescribing Pattern of Drugs in Chronic Kidney Disease Patients in a Tertiary Care Hospital

Aasim Yousoof, Rakendra Singh, Mohammad Talat Ul Tuba Dar, Ansar Ahmad Paray, Md Chand

Objectives: To study the prescription pattern of drugs in chronic kidney disease (CKD) patients attending a tertiary care hospital.

Materials and methods: This prospective observational study was conducted at a tertiary care hospital in patients with chronic kidney disease. Patient demographic details, clinical profile, drug usage pattern was recorded using medication usage form and structured case report form and data were analysed using statistical software. Drug-drug interactions were checked using Lexicomp.

Results: A total of 60 patients recruited over a period of 3 months were included in the study and data was obtained. Mean age was 59 years. 63% were males and 37% were females. 52% were in stage 4 of chronic kidney disease [1]. Hypertension (64.9%) was most common comorbidity present followed by anaemia (61.4%), and diabetes (52.6%). A total number of 686 drugs were prescribed in 60 prescriptions. Median number of drugs prescribed per prescription was 11.43 Major classes of drugs prescribed were cardiovascular drugs (23.61%), haematopoietic agents (23.03%), gastrointestinal drugs (9.76%), multivitamins and Minerals (16.32%), anti-hypertensive drugs (11%), antibiotics (6.55%). Potential drug-drug interaction per prescription was 3.18. Out of total 686 drugs, 137 drugs were prescribed by generic name.

Conclusion: Due to multiple comorbidities associated with chronic kidney disease patients, large number of drugs were prescribed indicative of polypharmacy. Potential Drug-drug interactions were also significantly high in these patients. A large number of drugs were prescribed by generic name.